NEW YORK ( TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Monday's session.

Arrowhead Research ( ARWR) climbed by 6 cents, or 11.1%, to 60 cents in the premarket session after the company said its subsidiary, Calando Pharma, has demonstrated systemic delivery of siRNA and the successful "silencing" of a widely recognized cancer gene via RNA interference (RNAi) in humans. The data were published in the Nature journal Sunday in an advance online edition, the company said. The 50-day average daily volume for Arrowhead is 126,000, according to the Nasdaq.

Helios & Matheson North America ( HMNA) should trade lower Monday after the software company said its relationship with Cogito, a fellow software company whose products Helios & Matheson markets, will be terminated. Helios & Matheson said it expects that future software product revenues, which it views as supplemental to its core consulting business, "will be significantly reduced in the short term." The 50-day average daily volume for Helios & Matheson is 62,000. The stock closed Friday at $1.65.

Verenium ( VRNM) may also lose ground Monday after the biofuels company received a "going concern" qualification from its auditors. The 50-day average daily volume for Verenium is 176,000. The stock closed Friday at $6.13.

China GengSheng Minerals ( CHGS) may trade higher Monday after the materials technology company said it has entered two new sales contracts totaling approx $1.56 mln (RMB10.65 million) for refractory products with two new customers. The average daily volume for China GengSheng is 244,000. Shares closed Friday at $2.73.

-- Written by Robert Holmes in Boston.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of TheStreet.com on Facebook.

More from Investing

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Papa John's: The Noise and the Stock Price

Papa John's: The Noise and the Stock Price

CSX Rises on Earnings, Revenue Beat

CSX Rises on Earnings, Revenue Beat

United Beats Second Quarter Earnings Estimates

United Beats Second Quarter Earnings Estimates

Video: Here's How Goldman Sachs May Change Under David Solomon

Video: Here's How Goldman Sachs May Change Under David Solomon